GoAI
Get started
Medifast, Inc. logo

Medifast, Inc.

MED

NYSEConsumer CyclicalPersonal Products & Services

Open in GoAI

Previous close

$11.95

+$0.33 · +2.84%

Aug 21, 4:00 PM ET

MED company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

65

Undervalued

Momentum

34

Weakening

Sentiment

57

Mixed

Risk resilience

57

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.

Industry
Personal Products & Services
Sector
Consumer Cyclical
Headquarters
US
CEO
Nicholas Johnson
Listed since
Dec 30, 1993
Employees
380

Market position

Day range

Current $11.95

52-week range

Current $11.95

Open
$11.61
Previous close
$11.62
Volume
162.5K
0.77× average
Average volume
210.71K
Average daily volume
Market cap
132.87M USD
Beta
0.7
Market reference 1
50-day average
$10.943
+9.20% above average
200-day average
$11.1481
+7.19% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
44.76M USD
P/E (TTM)
-5.13×
P/B (TTM)
0.68×
P/S (TTM)
0.42×
EV / EBITDA
9.21×
Earnings yield
-15.92%
Free cash flow yield
1.06%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
69.24%
Operating margin
-5.46%
Net margin
-8.08%
Return on equity
-9.39%
Return on assets
-7.27%
Return on invested capital
-6.50%

Financial health

Debt / equity
0.14×
Current ratio
4.69×
Altman Z-score
3.85
Piotroski F-score
3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends82%50%19%-13%Gross margin, FY2021: 73.89%Gross margin, FY2022: 71.34%Gross margin, FY2023: 72.37%Gross margin, FY2024: 73.80%Gross margin, FY2025: 71.33%Operating margin, FY2021: 14.17%Operating margin, FY2022: 11.56%Operating margin, FY2023: 11.79%Operating margin, FY2024: 0.48%Operating margin, FY2025: -3.68%Net margin, FY2021: 10.75%Net margin, FY2022: 8.98%Net margin, FY2023: 9.27%Net margin, FY2024: 0.35%Net margin, FY2025: -4.84%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 73.89%. Gross margin FY2022 71.34%. Gross margin FY2023 72.37%. Gross margin FY2024 73.80%. Gross margin FY2025 71.33%. Operating margin FY2021 14.17%. Operating margin FY2022 11.56%. Operating margin FY2023 11.79%. Operating margin FY2024 0.48%. Operating margin FY2025 -3.68%. Net margin FY2021 10.75%. Net margin FY2022 8.98%. Net margin FY2023 9.27%. Net margin FY2024 0.35%. Net margin FY2025 -4.84%.

Income trends

Revenue

385.79M USD-35.96%

Operating income

−14.21M USD−17.09M USD

Net income

−18.67M USD−20.76M USD
Income trends across reported periods1.76B USD1.11B USD466.5M USD−180.4M USDRevenue, FY2021: 1.53B USDRevenue, FY2022: 1.6B USDRevenue, FY2023: 1.07B USDRevenue, FY2024: 602.46M USDRevenue, FY2025: 385.79M USDOperating income, FY2021: 216.24M USDOperating income, FY2022: 184.81M USDOperating income, FY2023: 126.4M USDOperating income, FY2024: 2.88M USDOperating income, FY2025: −14.21M USDNet income, FY2021: 164.03M USDNet income, FY2022: 143.57M USDNet income, FY2023: 99.42M USDNet income, FY2024: 2.09M USDNet income, FY2025: −18.67M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.53B USD. Revenue FY2022 1.6B USD. Revenue FY2023 1.07B USD. Revenue FY2024 602.46M USD. Revenue FY2025 385.79M USD. Operating income FY2021 216.24M USD. Operating income FY2022 184.81M USD. Operating income FY2023 126.4M USD. Operating income FY2024 2.88M USD. Operating income FY2025 −14.21M USD. Net income FY2021 164.03M USD. Net income FY2022 143.57M USD. Net income FY2023 99.42M USD. Net income FY2024 2.09M USD. Net income FY2025 −18.67M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue385.79M USD602.46M USD1.07B USD1.6B USD1.53B USD
Cost of goods sold110.6M USD157.84M USD296.2M USD458.16M USD398.49M USD
Gross profit275.19M USD444.62M USD775.85M USD1.14B USD1.13B USD
Selling, general, and administrative289.4M USD441.75M USD649.45M USD955.61M USD911.36M USD
Operating expenses289.4M USD441.75M USD649.45M USD955.61M USD911.36M USD
Interest income5.52M USD4.8M USD2.49M USD——
Interest expense———701K USD231K USD
Depreciation and amortization10.5M USD12.71M USD13.11M USD10.98M USD6.81M USD
Operating income−14.21M USD2.88M USD126.4M USD184.81M USD216.24M USD
Net income−18.67M USD2.09M USD99.42M USD143.57M USD164.03M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
82%
9 beats, 2 misses, 0 met estimates
Average EPS surprise
-84.26%
11 comparable reports
Latest EPS result
-0.28
Estimate -0.65 · Beat by 56.92%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.31-0.07-0.46-0.84Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25MissQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 18, 2025: actual 0.1, estimate -0.16, surprise +162.50%, Beat. Q2 2025, reported Apr 28, 2025: actual -0.11, estimate -0.25, surprise +56.00%, Beat. Q3 2025, reported Aug 4, 2025: actual 0.23, estimate -0.19, surprise +221.05%, Beat. Q4 2025, reported Nov 3, 2025: actual -0.21, estimate -0.01, surprise -2000.00%, Miss. Q1 2026, reported Feb 17, 2026: actual -0.55, estimate -0.76, surprise +27.63%, Beat. Q2 2026, reported May 4, 2026: actual -0.19, estimate -0.55, surprise +65.45%, Beat. Q3 2026, reported Aug 3, 2026: actual -0.28, estimate -0.65, surprise +56.92%, Beat. Q4 2026, reported Nov 2, 2026: actual —, estimate -0.35, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates123.76M103.99M84.21M64.44MQ1 '25BeatQ2 '25MissQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 18, 2025: actual 119M USD, estimate 114.25M USD, surprise +4.16%, Beat. Q2 2025, reported Apr 28, 2025: actual 115.73M USD, estimate 116.4M USD, surprise -0.58%, Miss. Q3 2025, reported Aug 4, 2025: actual 105.56M USD, estimate 101.8M USD, surprise +3.69%, Beat. Q4 2025, reported Nov 3, 2025: actual 89.41M USD, estimate 71.4M USD, surprise +25.22%, Beat. Q1 2026, reported Feb 17, 2026: actual 75.1M USD, estimate 71.4M USD, surprise +5.18%, Beat. Q2 2026, reported May 4, 2026: actual 76.04M USD, estimate 69.2M USD, surprise +9.89%, Beat. Q3 2026, reported Aug 3, 2026: actual 76.38M USD, estimate 72.7M USD, surprise +5.07%, Beat. Q4 2026, reported Nov 2, 2026: actual —, estimate 71.3M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$59.67

399.33% upside
Past 12 months12-month forecastHigh $150Average $59.67Low $12.00

Rating distribution

12 ratings
Strong buy00%
Buy433%
Hold650%
Sell217%
Strong sell00%

Recent analyst actions

2 institutions
Stephens & Co.maintainEqual Weight

MED news

zacks.com

Can Medifast's New Compensation Plan Accelerate Coach Growth?

MED is reshaping its coach network around Executive Directors as productivity rises despite a sharp decline in active earning coaches.

Read source
zacks.com

Can Medifast's Coach Productivity Gains Help Revive Revenue Growth?

MED's improving coach productivity and client retention point to stabilization, but a shrinking coach base remains a challenge.

Read source
zacks.com

Is MED Worth Buying as Low Valuation Meets a High-Risk Turnaround?

Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach base and weak growth keep the turnaround high risk.

Read source
zacks.com

MED Rallies 13.6% in the Past Month: Can the Momentum Keep Building?

Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations support momentum despite weaker revenue.

Read source
zacks.com

Can MED's Trilivy Launch and Cost Cuts Drive a Q4 Profit Turnaround?

Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue and its coach base keep risks high.

Read source
seekingalpha.com

Medifast: Worth A Speculative Entry As Sales Stabilize (Rating Upgrade)

Medifast, Inc. has started to report stabilizing sales through improved coach productivity, shown again in the Q2 report. Stabilized sales provide a pathway to stabilize earnings. MED targets profitability by Q4 already,…

Read source

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

$6.56

2022 complete year+199.5% since 2018

Corporate action history

Dividend

Ex-dividend Sep 18, 2023

$1.65

Quarterly

Record Sep 19, 2023 · Payment Nov 7, 2023

Dividend

Ex-dividend Jun 26, 2023

$1.65

Quarterly

Record Jun 27, 2023 · Payment Aug 8, 2023

Dividend

Ex-dividend Mar 27, 2023

$1.65

Quarterly

Record Mar 28, 2023 · Payment May 9, 2023

Dividend

Ex-dividend Dec 19, 2022

$1.64

Quarterly

Record Dec 20, 2022 · Payment Feb 7, 2023

Dividend

Ex-dividend Sep 19, 2022

$1.64

Quarterly

Record Sep 20, 2022 · Payment Nov 8, 2022

Dividend

Ex-dividend Jun 27, 2022

$1.64

Quarterly

Record Jun 28, 2022 · Payment Aug 8, 2022

MED peers

The Home Depot, Inc. logo

HD

The Home Depot, Inc.

$335.61

+0.33%

Alibaba Group Holding Limited logo

BABA

Alibaba Group Holding Limited

$119.32

-8.59%

Toyota Motor Corporation logo

TM

Toyota Motor Corporation

$197.35

+2.66%

McDonald's Corporation logo

MCD

McDonald's Corporation

$270.95

+0.68%

The TJX Companies, Inc. logo

TJX

The TJX Companies, Inc.

$140.51

-0.13%

Lowe's Companies, Inc. logo

LOW

Lowe's Companies, Inc.

$216.09

-0.58%

ETFs holding MED

Funds reporting this stock among their holdings, ordered by reported position size.

Avantis U.S. Small Cap Value ETF logoAvantis U.S. Small Cap Value ETFAVUV
Market value
4.06M
Weight
0.01%
AUM
31.27B USD
Expense ratio
0.25%
Price / 1D
$126.45+0.66%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
3.14M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Schwab Fundamental U.S. Small Company Index ETF logoSchwab Fundamental U.S. Small Company Index ETFFNDA
Market value
3.07M
Weight
0.03%
AUM
9.26B USD
Expense ratio
0.25%
Price / 1D
$37.73+0.75%
iShares U.S. Small-Cap Equity Factor ETF logoiShares U.S. Small-Cap Equity Factor ETFSMLF
Market value
1.39M
Weight
0.03%
AUM
4.3B USD
Expense ratio
0.15%
Price / 1D
$89.29+0.80%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
1.14M
Weight
0.00%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
Dimensional - US Small Cap Value ETF logoDimensional - US Small Cap Value ETFDFSV
Market value
704.44K
Weight
0.01%
AUM
8.42B USD
Expense ratio
0.30%
Price / 1D
$40.29+0.72%
EA Bridgeway Omni Small-Cap Value ETF logoEA Bridgeway Omni Small-Cap Value ETFBSVO
Market value
610K
Weight
0.02%
AUM
1.71B USD
Expense ratio
0.47%
Price / 1D
$29.62+0.85%
Schwab U.S. Small-Cap ETF logoSchwab U.S. Small-Cap ETFSCHA
Market value
591.29K
Weight
0.00%
AUM
23.1B USD
Expense ratio
0.03%
Price / 1D
$34.83+0.52%

Continue in GoAI

Research MED

research.disclaimer